{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:05:30Z","timestamp":1784822730469,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00228-022-03415-x","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T06:02:59Z","timestamp":1668492179000},"page":"79-87","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Comparative polymyxin B pharmacokinetics in critically ill patients with renal insufficiency and in continuous veno-venous hemodialysis"],"prefix":"10.1007","volume":"79","author":[{"given":"Yury A.","family":"Surovoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksim A.","family":"Burkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna A.","family":"Galvidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail A.","family":"Sobolev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur Can","family":"Rende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei V.","family":"Tsarenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"issue":"2","key":"3415_CR1","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1128\/AAC.01222-13","volume":"58","author":"ME Falagas","year":"2014","unstructured":"Falagas ME, Lourida P, Poulikakos P et al (2014) Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother 58(2):654\u2013663","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"3415_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2217\/fmb.13.39","volume":"8","author":"T Velkov","year":"2013","unstructured":"Velkov T, Roberts KD, Nation RL et al (2013) Pharmacology of polymyxins: new insights into an \u2018old\u2019 class of antibiotics. Future Microbiol 8(6):711\u2013724","journal-title":"Future Microbiol"},{"issue":"1","key":"3415_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"BT Tsuji","year":"2019","unstructured":"Tsuji BT, Pogue JM, Zavascki AP et al (2019) International consensus guidelines for the optimal use of the polymyxins: endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy 39(1):10\u201339","journal-title":"Pharmacotherapy"},{"issue":"1","key":"3415_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/antibiotics8010031","volume":"8","author":"SN Avedissian","year":"2019","unstructured":"Avedissian SN, Liu J, Rhodes NJ et al (2019) A review of the clinical pharmacokinetics of polymyxin B. Antibiotics (Basel) 8(1):31","journal-title":"Antibiotics (Basel)"},{"issue":"6","key":"3415_CR5","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1128\/AAC.00035-06","volume":"50","author":"PJ Bergen","year":"2006","unstructured":"Bergen PJ, Li J, Rayner CR, Nation RL (2006) Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob Agents Chemother 50(6):1953\u20131958","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3415_CR6","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1128\/AAC.02445-15","volume":"60","author":"P Manchandani","year":"2016","unstructured":"Manchandani P, Zhou J, Ledesma KR et al (2016) Characterization of polymyxin B biodistribution and disposition in an animal model. Antimicrob Agents Chemother 60(2):1029\u20131034","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3415_CR7","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1124\/pharmrev.120.000020","volume":"73","author":"SC Nang","year":"2021","unstructured":"Nang SC, Azad MAK, Velkov T et al (2021) Rescuing the last-line polymyxins: achievements and challenges. Pharmacol Rev 73(2):679\u2013728","journal-title":"Pharmacol Rev"},{"issue":"2","key":"3415_CR8","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1186\/cc6863","volume":"12","author":"SM Bagshaw","year":"2008","unstructured":"Bagshaw SM, George C, Bellomo R (2008) Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care 12(2):R47","journal-title":"Crit Care"},{"issue":"3","key":"3415_CR9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2215\/CJN.03681106","volume":"2","author":"SM Bagshaw","year":"2007","unstructured":"Bagshaw SM, Uchino S, Bellomo R et al (2007) Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2(3):431\u2013439","journal-title":"Clin J Am Soc Nephrol"},{"key":"3415_CR10","doi-asserted-by":"publisher","unstructured":"Pogue JM, Tam VH (2019) Toxicity in Patients. In: Li J, Nation R, Kaye K (eds) Polymyxin antibiotics: from laboratory bench to bedside. Adv Exp Med Biol vol 1145. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-030-16373-0_17","DOI":"10.1007\/978-3-030-16373-0_17"},{"issue":"7","key":"3415_CR11","doi-asserted-by":"publisher","first-page":"e00483","DOI":"10.1128\/AAC.00483-18","volume":"62","author":"EA Lakota","year":"2018","unstructured":"Lakota EA, Landersdorfer CB, Nation RL et al (2018) Personalizing polymyxin B dosing using an adaptive feedback control algorithm. Antimicrob Agents Chemother 62(7):e00483\u2013e518","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"3415_CR12","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/cid\/cit334","volume":"57","author":"AM Sandri","year":"2013","unstructured":"Sandri AM, Landersdorfer CB, Jacob J et al (2013) Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens. Clin Infect Dis 57(4):524\u2013531","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3415_CR13","doi-asserted-by":"publisher","first-page":"e01493","DOI":"10.1128\/AAC.01493-17","volume":"62","author":"CJ Kubin","year":"2018","unstructured":"Kubin CJ, Nelson BC, Miglis C et al (2018) Population pharmacokinetics of intravenous polymyxin B from clinical samples. Antimicrob Agents Chemother 62(3):e01493\u2013e1517","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3415_CR14","doi-asserted-by":"publisher","first-page":"e01337","DOI":"10.1128\/AAC.01337-16","volume":"61","author":"V Thamlikitkul","year":"2017","unstructured":"Thamlikitkul V, Dubrovskaya Y, Manchandani P et al (2017) Dosing and pharmacokinetics of polymyxin B in Patients with renal insufficiency. Antimicrob Agents Chemother 61(1):e01337\u2013e1416","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3415_CR15","doi-asserted-by":"publisher","first-page":"e01900","DOI":"10.1128\/AAC.01900-20","volume":"65","author":"P Wang","year":"2021","unstructured":"Wang P, Zhang Q, Zhu Z et al (2021) Comparing the population pharmacokinetics of and acute kidney injury due to polymyxin B in Chinese patients with or without renal insufficiency. Antimicrob Agents Chemother 65(2):e01900\u2013e1920","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"3415_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000363495","volume":"37","author":"PM Honor\u00e9","year":"2014","unstructured":"Honor\u00e9 PM, Jacobs R, Joannes-Boyau O et al (2014) Continuous renal replacement therapy-related strategies to avoid colistin toxicity: a clinically orientated review. Blood Purif 37(4):291\u2013295","journal-title":"Blood Purif"},{"issue":"5","key":"3415_CR17","first-page":"565","volume":"64","author":"RL Nation","year":"2017","unstructured":"Nation RL, Garonzik SM, Thamlikitkul V et al (2017) Dosing guidance for intravenous colistin in critically-ill patients. Clin Infect Dis 64(5):565\u2013571","journal-title":"Clin Infect Dis"},{"issue":"7","key":"3415_CR18","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1097\/CCM.0b013e3181aab3d0","volume":"37","author":"G Choi","year":"2009","unstructured":"Choi G, Gomersall CD, Tian Q et al (2009) Principles of antibacterial dosing in continuous renal replacement therapy. Crit Care Med 37(7):2268\u20132282","journal-title":"Crit Care Med"},{"key":"3415_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106214","volume":"175","author":"X Luo","year":"2022","unstructured":"Luo X, Zhang Y, Liang P et al (2022) Population pharmacokinetics of polymyxin B and dosage strategy in critically ill patients with\/without continuous renal replacement therapy. Eur J Pharm Sci 175:106214","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"3415_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2022.106599","volume":"60","author":"P Wang","year":"2022","unstructured":"Wang P, Xing H, Zhang F et al (2022) Population pharmacokinetics of polymyxin B in critically ill patients receiving continuous venovenous haemofiltration. Int J Antimicrob Agents 60(1):106599","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"3415_CR21","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/jac\/dks437","volume":"68","author":"AM Sandri","year":"2013","unstructured":"Sandri AM, Landersdorfer CB, Jacob J et al (2013) Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis. J Antimicrob Chemother 68(3):674\u2013677","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"3415_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31\u201341","journal-title":"Nephron"},{"key":"3415_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2021.114275","volume":"204","author":"MA Burkin","year":"2021","unstructured":"Burkin MA, Galvidis IA, Surovoy YA et al (2021) Development of ELISA formats for polymyxin B monitoring in serum of critically ill patients. J Pharm Biomed Anal 204:114275","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"3415_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ijantimicag.2015.11.007","volume":"47","author":"MH Rigatto","year":"2016","unstructured":"Rigatto MH, Falci DR, Lopes NT et al (2016) Clinical features and mortality of patients on renal replacement therapy receiving polymyxin B. Int J Antimicrob Agents 47(2):146\u2013150","journal-title":"Int J Antimicrob Agents"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-022-03415-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-022-03415-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-022-03415-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T03:04:16Z","timestamp":1672974256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-022-03415-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["3415"],"URL":"https:\/\/doi.org\/10.1007\/s00228-022-03415-x","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"assertion":[{"value":"2 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was conducted in accordance with the Declaration of Helsinki and national and institutional standards. This study was approved by MEDSI Clinic Independent Ethical Committee, Moscow, Russia (Protocol #29 April 15, 2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent form was signed by legal representatives of the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent form was signed by legal representatives of the patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}